| Recruiting | To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Yea HPV Infection, HPV-Related Carcinoma, HPV-Related Intraepithelial Neoplasia | Phase 2 | 2025-01-15 |
| Active Not Recruiting | A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 HPV Infection, HPV-Related Carcinoma, Genital Wart | Phase 1 | 2024-08-03 |
| Active Not Recruiting | A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese M Genital Wart, Penile Cancer, Anal Cancer | Phase 3 | 2024-07-11 |
| Terminated | A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Ch Cervical Cancer, Genital Wart, CIN1 | Phase 3 | 2022-12-09 |
| Completed | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old Penile Cancer, Anal Cancer, PIN-1 | Phase 1 | 2022-09-23 |
| Recruiting | Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer | — | 2022-05-14 |
| Recruiting | Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer | Phase 3 | 2021-09-15 |
| Recruiting | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year HPV Infections, Cervical Cancer, Vulvar Cancer | Phase 3 | 2021-05-28 |
| Completed | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females HPV Infections, Cervical Cancer, Vulvar Cancer | Phase 3 | 2020-09-19 |
| Completed | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem Cervical Cancer, Vulvar Cancer, Vaginal Cancer | Phase 3 | 2020-05-28 |
| Recruiting | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female Cervical Cancer, Vulvar Cancer, Vaginal Cancer | Phase 3 | 2020-04-28 |
| Completed | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Cervical Cancers, Vulvar Cancer, Vaginal Cancer | Phase 1 | 2018-10-10 |
| Completed | A Phase I Study of Quadrivalent HPV Recombinant Vaccine HPV Infections | Phase 1 | 2016-12-01 |